The growing demand for GLP-1 drugs has raised concerns about potential misuse and the lack of evidence guiding their use ...
New expert consensus highlights the potential benefits and risks of GLP-1 medications for people with eating disorders and ...
UCLA researchers identified a GGPP-Rho-YAP signaling pathway in hepatic stellate cells around MASLD-related liver tumors that ...
Incyte (NASDAQ:INCY) presented updated clinical data and development plans for two experimental solid-tumor programs at ESMO in Madrid: INCA33890, a TGFβR2-by-PD-1 bispecific antibody known as “’890,” ...
Morning Overview on MSN
Daily vitamin C was linked to better survival in a 109-person phase 2 trial of people with precancerous blood disorders
In a randomised, double-blind, placebo-controlled phase 2 trial of 109 people with two precancerous blood conditions, those ...
An observational study found hidden immune activity and a distinctive gut environment in bowel disease associated with PSC, ...
A nirjala fast asks something unusual of the body: not just the absence of food, but the complete withdrawal of water for ...
A new proposal calls for federal investment to study how early microbial disruptions contribute to conditions like asthma and ...
Parade Pets on MSN
Make Your Dog's Dental Routine Easier With This Toothbrushing Kit From Target—Now on Sale
Your dog's teeth called, and it's time for a cleaning.
Oral and hand, foot and mouth ulcers both cause mouth ulcers, pain, making it difficult for children to eat and drink.
Researchers also found that people who ate less fast food, drank fewer carbonated soft drinks, and ate spicy foods less frequently tended to have lower odds of having Crohn's, regardless of how often ...
Shares of ArriVent BioPharma rose after the company announced positive initial data from a Phase 1 trial of treatment for gastrointestinal cancers. The stock gained 9.3% to $22.95 in premarket trading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results